Gilead Sciences
Utility Patents

Last updated:

List of all Gilead Sciences patents 121 in total

Status Patent
Grant
Utility: Thiadiazole IRAK4 compounds External link
Filling date: 5 Sep 2025 Issue date: 29 Jun 2021
Grant
Utility: Therapeutic heterocyclic compounds External link
Filling date: 5 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Compounds for the treatment of HIV External link
Filling date: 5 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Phosphatidylinositol 3-kinase inhibitors External link
Filling date: 5 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: Methods for treating arenaviridae and coronaviridae virus infections External link
Filling date: 5 Sep 2025 Issue date: 18 May 2021
Grant
Utility: MCL-1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs External link
Filling date: 5 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: FXR (NR1H4) modulating compounds External link
Filling date: 5 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Combination therapy comprising an ACC inhibitor External link
Filling date: 5 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Synthesis of polycyclic-carbamoylpyridone compounds External link
Filling date: 5 Sep 2025 Issue date: 13 Apr 2021
Grant
Utility: Cot modulators and methods of use thereof External link
Filling date: 5 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Solid forms of an ASK1 inhibitor External link
Filling date: 5 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: 2'-substituted carba-nucleoside analogs for antiviral treatment External link
Filling date: 5 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: Method of purifying an antibody External link
Filling date: 5 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: PD-1/PD-L1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Human immunodeficiency virus neutralizing antibodies External link
Filling date: 5 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Multispecific antibodies that target HIV GP120 and CD3 External link
Filling date: 5 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections External link
Filling date: 5 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Pyrrolo[1,2-B]pyridazine derivatives External link
Filling date: 5 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: Substituted pyrrolizine compounds and uses thereof External link
Filling date: 5 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: Antibodies and fragments thereof that bind hepatitis B virus protein X External link
Filling date: 5 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Choline salt forms of an HIV capsid inhibitor External link
Filling date: 5 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)- oxy)methyl)(phenoxy)phosphoryl(-L-alaninate External link
Filling date: 5 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Substituted pyrrolizine compounds and uses thereof External link
Filling date: 5 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Therapeutic compounds External link
Filling date: 5 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(p- henoxy) phosphoryl)amino)propanoate External link
Filling date: 5 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidaz- o[1,2-a]pyrazin-8-amine External link
Filling date: 5 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Therapeutic compounds External link
Filling date: 5 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Compositions and methods of treating HIV External link
Filling date: 5 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: FXR (NR1H4) modulating compounds External link
Filling date: 5 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: PD-1/PD-L1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: HIV protease inhibitors External link
Filling date: 5 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: HIV inhibitor compounds External link
Filling date: 5 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Processes for preparing ACC inhibitors and solid forms thereof External link
Filling date: 5 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Apoptosis signal-regulating kinase inhibitors External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: PD-1/PD-L1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: MCL-1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Methods and intermediates for preparing therapeutic compounds External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Methods for treating filoviridae virus infections External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Methods for treating arenaviridae and coronaviridae virus infections External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Methods and compounds for treating paramyxoviridae virus infections External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1',2':4,5]pyrazino[2,1- -b][1,3]oxazocines and methods for treating viral infections External link
Filling date: 5 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Methods of treating feline coronavirus infections External link
Filling date: 5 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections External link
Filling date: 5 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Polycyclic-carbamoylpyridone compounds and their pharmaceutical use External link
Filling date: 5 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Therapeutic compounds External link
Filling date: 5 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Polycyclic-carbamoylpyridone compounds and their pharmaceutical use External link
Filling date: 5 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Toll like receptor modulator compounds External link
Filling date: 5 Sep 2025 Issue date: 5 May 2020
Grant
Utility: Processes for preparing ASK1 inhibitors External link
Filling date: 5 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Cot modulators and methods of use thereof External link
Filling date: 5 Sep 2025 Issue date: 3 Mar 2020

Showing 50 to 100 of 121 patents.